Genmab A/S (GMAB)
29.96
+0.31
(+1.05%)
USD |
NASDAQ |
May 17, 16:00
29.96
0.00 (0.00%)
After-Hours: 20:00
Genmab Price: 29.96 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 16, 2024 | 29.71 | 29.83 | 29.50 | 29.65 | 587476.0 |
| May 15, 2024 | 29.84 | 30.41 | 29.73 | 30.22 | 514415.0 |
| May 14, 2024 | 29.35 | 29.53 | 29.24 | 29.53 | 652226.0 |
| May 13, 2024 | 28.75 | 29.52 | 28.69 | 29.16 | 688696.0 |
| May 10, 2024 | 28.90 | 28.92 | 28.71 | 28.84 | 259973.0 |
| May 09, 2024 | 28.66 | 28.95 | 28.66 | 28.81 | 330417.0 |
| May 08, 2024 | 29.22 | 29.25 | 28.74 | 28.80 | 592927.0 |
| May 07, 2024 | 28.96 | 29.36 | 28.89 | 29.29 | 676857.0 |
| May 06, 2024 | 29.15 | 29.29 | 28.89 | 29.03 | 406782.0 |
| May 03, 2024 | 29.73 | 29.92 | 29.46 | 29.72 | 721270.0 |
| May 02, 2024 | 28.27 | 28.27 | 27.42 | 27.72 | 667530.0 |
| May 01, 2024 | 28.05 | 29.00 | 27.97 | 28.75 | 876260.0 |
| Apr 30, 2024 | 27.94 | 28.40 | 27.66 | 27.69 | 933126.0 |
| Apr 29, 2024 | 28.01 | 28.65 | 28.01 | 28.57 | 593112.0 |
| Apr 26, 2024 | 28.09 | 28.18 | 27.90 | 28.15 | 339610.0 |
| Apr 25, 2024 | 27.66 | 27.80 | 27.43 | 27.46 | 436367.0 |
| Apr 24, 2024 | 28.75 | 28.76 | 28.09 | 28.47 | 456129.0 |
| Apr 23, 2024 | 28.76 | 29.04 | 28.54 | 28.56 | 560041.0 |
| Apr 22, 2024 | 28.85 | 29.21 | 28.72 | 28.97 | 452366.0 |
| Apr 19, 2024 | 28.47 | 28.81 | 28.45 | 28.70 | 361029.0 |
| Apr 18, 2024 | 28.46 | 28.62 | 28.29 | 28.33 | 243953.0 |
| Apr 17, 2024 | 28.78 | 28.84 | 28.44 | 28.53 | 358638.0 |
| Apr 16, 2024 | 29.06 | 29.61 | 28.77 | 29.43 | 342404.0 |
| Apr 15, 2024 | 29.36 | 29.67 | 29.26 | 29.51 | 544079.0 |
| Apr 12, 2024 | 29.76 | 29.79 | 29.15 | 29.26 | 413219.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
17.15
Minimum
Mar 16 2020
48.72
Maximum
Sep 03 2021
33.56
Average
35.26
Median
Jul 28 2020
Price Benchmarks
| Ascendis Pharma A/S | 120.97 |
| Novo Nordisk A/S | 131.88 |
| Galecto Inc | 0.6179 |
| Evaxion Biotech AS | 3.72 |
| IO Biotech Inc | 1.39 |
Price Related Metrics
| PE Ratio | 24.83 |
| PS Ratio | 7.632 |
| PEG Ratio | 2.393 |
| Price to Book Value | 4.117 |
| Price to Free Cash Flow | 25.24 |
| Earnings Yield | 4.03% |
| Market Cap | 19.35B |
| PEGY Ratio | 2.393 |
| Operating PE Ratio | 23.85 |
| Normalized PE Ratio | 26.75 |